Source
From SEC EDGAR
168 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
Black Hills Corp. Reports 2026 Third-Quarter Results and Reaffirms 2026 Earnings Guidance
Reaffirms 2026 adjusted earnings guidance in the range of $4.25 to $4.45 per share, excluding merger-related costs
CrossAmerica Partners LP Reports Third Quarter 2026 Results
Reported Third Quarter of 2026 Net Income of $8.8 million, Adjusted EBITDA of $38.7 million and Distributable Cash Flow of $21.8 million compared to…
Excelerate Energy, Inc.
Excelerate Energy Reports Strong Third Quarter 2026 Results
ATN International, Inc. Reports Third Quarter 2026 Results and Updates 2026 Full Year Outlook
Reports a 32% increase in operating income and consistent year-over-year revenue and Adjusted EBITDA1
CF Industries Holdings, Inc.
CF Industries Holdings, Inc. Reports First Nine Months 2026 Net Earnings of $1.78 Billion, Adjusted EBITDA of $3.01 Billion
Tigo Energy Reports Third Quarter 2026 Financial Results
Dave Reports Third Quarter 2026 Financial Results
Q3 Revenue Growth Accelerates to 31% Y/Y to $198 Million, Driven by Record New Member Acquisition as well as Continued MTM Growth and ARPU Expansion
Figma Announces Third Quarter 2026 Financial Results
Q3 revenue grew 43% year-over-year to $391.4 million, $16.4 million above the high-end of prior guidance.
COTY ANNOUNCES FIRST QUARTER FISCAL YEAR 2027 RESULTS
Q1 Profit and EPS Ahead of Guidance; Modest Sales Decline of 1%, with LFL Sales Down 2%
Nature's Sunshine Reports Third Quarter 2026 Results
Granite Point Mortgage Trust Inc. Reports
Third Quarter 2026 Financial Results
PreTRM® test volume increases 54% sequentially and approximately five-fold from 1Q26
Ordering healthcare providers increase 34% sequentially and approximately three-fold from 1Q26
American Bitcoin Reports Third Quarter 2026 Results
Grows Bitcoin Reserve Through Mining Operations, Increases Satoshis Per Share by Approximately 5%
HCI Group Reports Third Quarter 2026 Results
Third Quarter Pre-Tax Income of $116 million
Acadia Pharmaceuticals Reports Third Quarter 2026 Financial Results
- Third quarter GAAP total revenues of $342 million, up 22% year-over-year as compared to non-GAAP adjusted total revenues